Literature DB >> 16954815

Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms.

S A Mousa1, X Feng, J Xie, Y Du, Y Hua, H He, L O'Connor, R J Linhardt.   

Abstract

To determine the proangiogenesis effect of series of saccharides and a synthetic oligosaccharide and potential mechanisms, an in vitro 3-dimensional endothelial cell sprouting (3D-ECS) assay and the chick chorioallantoic membrane (CAM) model were used. We demonstrated that a sulfated oligosaccharide significantly promotes the endothelial capillary network initiated by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF). Furthermore, although the capillary network initiated by VEGF and b-FGF lasts no more than 7 days, addition of a sulfated oligosaccharide significantly amplifies angiogenesis and stabilizes the capillary network of new blood vessels. In the CAM model, sulfated oligosaccharide also stimulated angiogenesis. In both the CAM and the 3D-ECS assay, structure-function studies reveal that increased saccharide chain length up to the hexa- to decasaccharide show optimal proangiogenesis efficacy. In addition, the sulfation and molecular shape (branched vs linear) of oligosaccharide are important for sustained proangiogenesis efficacy. Data indicate that chemically defined synthetic oligosaccharides can play an important role in regulation of capillary structure and stability, which may contribute to future advances in therapeutic angiogenesis. The proangiogenesis efficacy of an oligosaccharide is mediated via integrin alphavbeta3 and involves mitogen-activated protein kinase signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954815      PMCID: PMC4140568          DOI: 10.1097/01.fjc.0000238591.90062.62

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.271


  32 in total

Review 1.  Regulation of angiogenesis: a new function of heparin.

Authors:  J Folkman
Journal:  Biochem Pharmacol       Date:  1985-04-01       Impact factor: 5.858

2.  Control of angiogenesis with synthetic heparin substitutes.

Authors:  J Folkman; P B Weisz; M M Joullié; W W Li; W R Ewing
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

Review 3.  Angiogenic protein therapy.

Authors:  Marc Ruel; Frank W Sellke
Journal:  Semin Thorac Cardiovasc Surg       Date:  2003-07

4.  Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.

Authors:  Shaker A Mousa; S Mohamed
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

5.  Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen.

Authors:  R W Colman; R A Pixley; I M Sainz; J S Song; I Isordia-Salas; S N Muhamed; J A Powell; S A Mousa
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

6.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

Authors:  R E Edens; A al-Hakim; J M Weiler; D G Rethwisch; J Fareed; R J Linhardt
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

7.  Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.

Authors:  Shaker A Mousa; Seema Mohamed
Journal:  Oncol Rep       Date:  2004-10       Impact factor: 3.906

8.  Synthesis and biological activities of octyl 2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-beta-L-fucopyranoside.

Authors:  Yuxia Hua; Yuguo Du; Gangli Yu; Shidong Chu
Journal:  Carbohydr Res       Date:  2004-08-23       Impact factor: 2.104

9.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

10.  Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.

Authors:  Alok A Khorana; Abha Sahni; Owen D Altland; Charles W Francis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

View more
  6 in total

1.  Inhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury.

Authors:  Elizabeth Lau; Richard U Margolis
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-10-16       Impact factor: 2.557

2.  Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.

Authors:  Thangirala Sudha; Murat Yalcin; Hung-Yun Lin; Ahmed M Elmetwally; Tipu Nazeer; Thiruvengadam Arumugam; Patricia Phillips; Shaker A Mousa
Journal:  Cancer Lett       Date:  2014-04-24       Impact factor: 8.679

3.  Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.

Authors:  Wenjing Zhao; Scott A McCallum; Zhongping Xiao; Fuming Zhang; Robert J Linhardt
Journal:  Biosci Rep       Date:  2012-02       Impact factor: 3.840

4.  Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis.

Authors:  Marlena Zielinska; Ewa Sawosz; Marta Grodzik; Mateusz Wierzbicki; Maria Gromadka; Anna Hotowy; Filip Sawosz; Andrzej Lozicki; Andrè Chwalibog
Journal:  Int J Nanomedicine       Date:  2011-12-06

5.  Fibrin and collagen differentially but synergistically regulate sprout angiogenesis of human dermal microvascular endothelial cells in 3-dimensional matrix.

Authors:  Xiaodong Feng; Marcia G Tonnesen; Shaker A Mousa; Richard A F Clark
Journal:  Int J Cell Biol       Date:  2013-04-30

6.  Glycosyl ortho-(1-phenylvinyl)benzoates versatile glycosyl donors for highly efficient synthesis of both O-glycosides and nucleosides.

Authors:  Penghua Li; Haiqing He; Yunqin Zhang; Rui Yang; Lili Xu; Zixi Chen; Yingying Huang; Limei Bao; Guozhi Xiao
Journal:  Nat Commun       Date:  2020-01-21       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.